Overactive bladder disorders cause the sudden urge to urinate and often the lack of control of urination, also known as incontinence. The condition can be inconvenient at best, embarrassing and debilitating in extreme cases. Someone suffering from overactive bladder might start avoiding social situations and public places to avoid potentially embarrassing situations.
The condition might be managed behaviorally or through exercises to strengthen the bladder wall and pelvic floor muscles. When those methods fail to improve the symptoms, medication might be prescribed.
Clinical trials are underway to investigate new medications that may alleviate symptoms and even improve functionality. People suffering from overactive bladder might benefit from participating in a clinical trial if current treatment methods are not working well.
Aventiv Research is currently investigating a medication to help control overactive bladder syndrome. If you have been suffering from symptoms for more than six months, you may qualify to volunteer for the study.
Taking part in Our Studies can be beneficial if you are dissatisfied with your current treatment options. Volunteering for a study affords access to the newest science in a field of research and often the best medical care available in the field. Subjects can contribute to the body of research and potentially help millions of other people suffering from the same condition.
This is a great way to make extra money and be involved in a research study that will help and benefit many people to come. I’ve really enjoyed myself with the program and with the staff.
"Thank you for your courtesy and kindness. I felt confident and comfortable. I would recommend the research study here. My coordinator was awesome and very caring."
Any stigma or hesitation about clinical research should be disregarded. A good learning program for research studies.
It's a good way to find out if there's some new drugs that can help people that have problems like mine and the people here are just wonderful to work with.